Traws Pharma, Inc. (TRAW) Operating margin 2015–2024
Traws Pharma, Inc. (TRAW) operating margin by fiscal year — reported operating income divided by reported revenue.
-640.7%FY2024 · since FY2015: -427.4% → -640.7%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -640.7% | +62356.7 pp |
| FY2023 | -62997.3% | -54015.9 pp |
| FY2022 | -8981.4% | -296.9 pp |
| FY2021 | -8684.5% | -1385.4 pp |
| FY2020 | -7299.1% | +3520.4 pp |
| FY2019 | -10819.5% | -9825.5 pp |
| FY2018 | -994.0% | +901.9 pp |
| FY2017 | -1895.9% | +1374.3 pp |
| FY2016 | -3270.3% | -2842.9 pp |
| FY2015 | -427.4% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More TRAW financial trends
TRAW RevenueTRAW Net incomeTRAW Net marginTRAW Gross profitTRAW Gross marginTRAW Operating incomeTRAW Operating cash flowTRAW Free cash flowTRAW Capital expendituresTRAW Return on equityTRAW Stock buybacksTRAW Dividends paidTRAW Total assetsTRAW Total liabilitiesTRAW Shareholders’ equityTRAW overview →